Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Guttman

Showing results (331-340 of 387) with videos related to

Pageof 39
Sort By:
The Journal of Allergy and Clinical Immunology|December 26, 2022
Skin TARC/CCL17 increase precedes the development of childhood atopic dermatitisAnne-Sofie Halling, Maria Rasmussen Rinnov, Iben Frier Ruge, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2023
Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) RegistryEric L Simpson, Anna De Benedetto, Mark Boguniewicz, et al.
Allergy|April 18, 2021
Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 responseAxel P Villani, Ana B Pavel, Jianni Wu, et al.
JAMA Dermatology|July 17, 2024
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical TrialAndrew Blauvelt, Emma Guttman-Yassky, Charles Lynde, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 4, 2018
Distinct transcriptomic profiles of early-onset atopic dermatitis in blood and skin of pediatric patientsPatrick M Brunner, Ariel Israel, Alexandra Leonard, et al.
The Journal of Allergy and Clinical Immunology|June 7, 2017
Prostaglandin E<sub>2</sub> stimulates adaptive IL-22 production and promotes allergic contact dermatitisCalum T Robb, Henry J McSorley, Jinju Lee, et al.
The British Journal of Dermatology|January 23, 2025
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)Jonathan I Silverberg, Lawrence F Eichenfield, Andrew Blauvelt, et al.
The British Journal of Dermatology|May 28, 2022
Distinct skin microbiome community structures in congenital ichthyosisKhek-Chian Tham, Rachel Lefferdink, Kaibo Duan, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|November 9, 2020
Dupilumab Significantly Modulates Pain and Discomfort in Patients With Atopic Dermatitis: A Post Hoc Analysis of 5 Randomized Clinical TrialsJonathan I Silverberg, Eric L Simpson, Emma Guttman-Yassky, et al.
Allergy|July 13, 2021
Early intervention and prevention of allergic diseasesHelen A Brough, Bruce Joshua Lanser, Sayantani B Sindher, et al.
Pageof 39

Showing results (331-340 of 387) with videos related to

Sort By:
Pageof 39
The Journal of Allergy and Clinical Immunology|December 26, 2022
Skin TARC/CCL17 increase precedes the development of childhood atopic dermatitisAnne-Sofie Halling, Maria Rasmussen Rinnov, Iben Frier Ruge, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2023
Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) RegistryEric L Simpson, Anna De Benedetto, Mark Boguniewicz, et al.
Allergy|April 18, 2021
Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 responseAxel P Villani, Ana B Pavel, Jianni Wu, et al.
JAMA Dermatology|July 17, 2024
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical TrialAndrew Blauvelt, Emma Guttman-Yassky, Charles Lynde, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 4, 2018
Distinct transcriptomic profiles of early-onset atopic dermatitis in blood and skin of pediatric patientsPatrick M Brunner, Ariel Israel, Alexandra Leonard, et al.
The Journal of Allergy and Clinical Immunology|June 7, 2017
Prostaglandin E<sub>2</sub> stimulates adaptive IL-22 production and promotes allergic contact dermatitisCalum T Robb, Henry J McSorley, Jinju Lee, et al.
The British Journal of Dermatology|January 23, 2025
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)Jonathan I Silverberg, Lawrence F Eichenfield, Andrew Blauvelt, et al.
The British Journal of Dermatology|May 28, 2022
Distinct skin microbiome community structures in congenital ichthyosisKhek-Chian Tham, Rachel Lefferdink, Kaibo Duan, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|November 9, 2020
Dupilumab Significantly Modulates Pain and Discomfort in Patients With Atopic Dermatitis: A Post Hoc Analysis of 5 Randomized Clinical TrialsJonathan I Silverberg, Eric L Simpson, Emma Guttman-Yassky, et al.
Allergy|July 13, 2021
Early intervention and prevention of allergic diseasesHelen A Brough, Bruce Joshua Lanser, Sayantani B Sindher, et al.
Pageof 39